You can buy or sell SBBP and other stocks, options, ETFs, and crypto commission-free!
Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. Read More The company was founded on May 26, 2015 and is headquartered in Lower Southampton, PA.
Lower Southampton, Pennsylvania
52 Week High
52 Week Low
The Motley FoolFeb 26
Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript
Strongbridge Biopharma plc (NASDAQ:SBBP) Q4 2018 Earnings Conference Call , 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning, ladies and gentlemen, and welcome to the Strongbridge Biopharma Corporate Update and Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions...
Expected May 9, Pre-Market